Naoki Shinojima

3PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 22, 2023
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors.

Naoki Shinojima, Kazutaka Ozono, Haruaki Yamamoto

|Feb 25, 2018
Clinical significance of polyglutamylation in primary central nervous system lymphoma.

Naoki Shinojima, Kenji Fujimoto, Keishi Makino

Pageof 1